United States Diabetic Nephropathy Market Report 2018

March 2018 | 109 pages | ID: U1418D5FC8BQEN
QYResearch

Abstracts

In this report, the United States Diabetic Nephropathy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Diabetic Nephropathy in these regions, from 2013 to 2025 (forecast).

United States Diabetic Nephropathy market competition by top manufacturers/players, with Diabetic Nephropathy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Eli Lilly
• Bayer AG
• Merk
• Nono Nordisk
• Mallinckrodt Pharmaceuticals
• Mitsubishi Tanabe Pharma Corporation
• Mesoblast Ltd
• Ampio Pharmaceuticals
• Reata Pharmaceuticals
• GenKyoTex S.A
• ChemoCentryx Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Mode of Treatment
• Drug Modifying Therapies
• Surgical Therapies
• Other
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Home Care
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Diabetic Nephropathy Market Report 2018

1 DIABETIC NEPHROPATHY OVERVIEW

1.1 Product Overview and Scope of Diabetic Nephropathy
1.2 Classification of Diabetic Nephropathy by Product Category
  1.2.1 United States Diabetic Nephropathy Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Diabetic Nephropathy Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Drug Modifying Therapies
  1.2.4 Surgical Therapies
  1.2.5 Other
1.3 United States Diabetic Nephropathy Market by Application/End Users
  1.3.1 United States Diabetic Nephropathy Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Home Care
  1.3.5 Other
1.4 United States Diabetic Nephropathy Market by Region
  1.4.1 United States Diabetic Nephropathy Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Diabetic Nephropathy Status and Prospect (2013-2025)
  1.4.3 Southwest Diabetic Nephropathy Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Diabetic Nephropathy Status and Prospect (2013-2025)
  1.4.5 New England Diabetic Nephropathy Status and Prospect (2013-2025)
  1.4.6 The South Diabetic Nephropathy Status and Prospect (2013-2025)
  1.4.7 The Midwest Diabetic Nephropathy Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Diabetic Nephropathy (2013-2025)
  1.5.1 United States Diabetic Nephropathy Sales and Growth Rate (2013-2025)
  1.5.2 United States Diabetic Nephropathy Revenue and Growth Rate (2013-2025)

2 UNITED STATES DIABETIC NEPHROPATHY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Diabetic Nephropathy Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Diabetic Nephropathy Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Diabetic Nephropathy Average Price by Players/Suppliers (2013-2018)
2.4 United States Diabetic Nephropathy Market Competitive Situation and Trends
  2.4.1 United States Diabetic Nephropathy Market Concentration Rate
  2.4.2 United States Diabetic Nephropathy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Diabetic Nephropathy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DIABETIC NEPHROPATHY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Diabetic Nephropathy Sales and Market Share by Region (2013-2018)
3.2 United States Diabetic Nephropathy Revenue and Market Share by Region (2013-2018)
3.3 United States Diabetic Nephropathy Price by Region (2013-2018)

4 UNITED STATES DIABETIC NEPHROPATHY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Diabetic Nephropathy Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Diabetic Nephropathy Revenue and Market Share by Type (2013-2018)
4.3 United States Diabetic Nephropathy Price by Type (2013-2018)
4.4 United States Diabetic Nephropathy Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DIABETIC NEPHROPATHY SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Diabetic Nephropathy Sales and Market Share by Application (2013-2018)
5.2 United States Diabetic Nephropathy Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DIABETIC NEPHROPATHY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Diabetic Nephropathy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.2 Diabetic Nephropathy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.2 Diabetic Nephropathy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merk
  6.4.2 Diabetic Nephropathy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merk Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Nono Nordisk
  6.5.2 Diabetic Nephropathy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nono Nordisk Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Mallinckrodt Pharmaceuticals
  6.6.2 Diabetic Nephropathy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mallinckrodt Pharmaceuticals Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Mitsubishi Tanabe Pharma Corporation
  6.7.2 Diabetic Nephropathy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Mitsubishi Tanabe Pharma Corporation Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Mesoblast Ltd
  6.8.2 Diabetic Nephropathy Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mesoblast Ltd Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Ampio Pharmaceuticals
  6.9.2 Diabetic Nephropathy Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ampio Pharmaceuticals Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Reata Pharmaceuticals
  6.10.2 Diabetic Nephropathy Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Reata Pharmaceuticals Diabetic Nephropathy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GenKyoTex S.A
6.12 ChemoCentryx Inc

7 DIABETIC NEPHROPATHY MANUFACTURING COST ANALYSIS

7.1 Diabetic Nephropathy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetic Nephropathy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Diabetic Nephropathy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetic Nephropathy Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DIABETIC NEPHROPATHY MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Diabetic Nephropathy Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Diabetic Nephropathy Sales Volume Forecast by Type (2018-2025)
11.3 United States Diabetic Nephropathy Sales Volume Forecast by Application (2018-2025)
11.4 United States Diabetic Nephropathy Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Diabetic Nephropathy
Figure United States Diabetic Nephropathy Market Size (K Units) by Type (2013-2025)
Figure United States Diabetic Nephropathy Sales Volume Market Share by Type (Product Category) in 2017
Figure Drug Modifying Therapies Product Picture
Figure Surgical Therapies Product Picture
Figure Other Product Picture
Figure United States Diabetic Nephropathy Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Diabetic Nephropathy by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Diabetic Nephropathy Market Size (Million USD) by Region (2013-2025)
Figure The West Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetic Nephropathy Sales (K Units) and Growth Rate (2013-2025)
Figure United States Diabetic Nephropathy Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetic Nephropathy Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Diabetic Nephropathy Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Diabetic Nephropathy Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetic Nephropathy Sales Share by Players/Suppliers
Figure 2017 United States Diabetic Nephropathy Sales Share by Players/Suppliers
Figure United States Diabetic Nephropathy Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Diabetic Nephropathy Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Diabetic Nephropathy Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetic Nephropathy Revenue Share by Players/Suppliers
Figure 2017 United States Diabetic Nephropathy Revenue Share by Players/Suppliers
Table United States Market Diabetic Nephropathy Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Diabetic Nephropathy Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Diabetic Nephropathy Market Share of Top 3 Players/Suppliers
Figure United States Diabetic Nephropathy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Diabetic Nephropathy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Diabetic Nephropathy Product Category
Table United States Diabetic Nephropathy Sales (K Units) by Region (2013-2018)
Table United States Diabetic Nephropathy Sales Share by Region (2013-2018)
Figure United States Diabetic Nephropathy Sales Share by Region (2013-2018)
Figure United States Diabetic Nephropathy Sales Market Share by Region in 2017
Table United States Diabetic Nephropathy Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Diabetic Nephropathy Revenue Share by Region (2013-2018)
Figure United States Diabetic Nephropathy Revenue Market Share by Region (2013-2018)
Figure United States Diabetic Nephropathy Revenue Market Share by Region in 2017
Table United States Diabetic Nephropathy Price (USD/Unit) by Region (2013-2018)
Table United States Diabetic Nephropathy Sales (K Units) by Type (2013-2018)
Table United States Diabetic Nephropathy Sales Share by Type (2013-2018)
Figure United States Diabetic Nephropathy Sales Share by Type (2013-2018)
Figure United States Diabetic Nephropathy Sales Market Share by Type in 2017
Table United States Diabetic Nephropathy Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Diabetic Nephropathy Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Diabetic Nephropathy by Type (2013-2018)
Figure Revenue Market Share of Diabetic Nephropathy by Type in 2017
Table United States Diabetic Nephropathy Price (USD/Unit) by Types (2013-2018)
Figure United States Diabetic Nephropathy Sales Growth Rate by Type (2013-2018)
Table United States Diabetic Nephropathy Sales (K Units) by Application (2013-2018)
Table United States Diabetic Nephropathy Sales Market Share by Application (2013-2018)
Figure United States Diabetic Nephropathy Sales Market Share by Application (2013-2018)
Figure United States Diabetic Nephropathy Sales Market Share by Application in 2017
Table United States Diabetic Nephropathy Sales Growth Rate by Application (2013-2018)
Figure United States Diabetic Nephropathy Sales Growth Rate by Application (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Novartis AG Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Novartis AG Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Eli Lilly Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Eli Lilly Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Bayer AG Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Bayer AG Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Merk Basic Information List
Table Merk Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merk Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Merk Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Merk Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Nono Nordisk Basic Information List
Table Nono Nordisk Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Nono Nordisk Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Nono Nordisk Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Nono Nordisk Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Mallinckrodt Pharmaceuticals Basic Information List
Table Mallinckrodt Pharmaceuticals Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mallinckrodt Pharmaceuticals Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Mallinckrodt Pharmaceuticals Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Mallinckrodt Pharmaceuticals Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Mitsubishi Tanabe Pharma Corporation Basic Information List
Table Mitsubishi Tanabe Pharma Corporation Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mitsubishi Tanabe Pharma Corporation Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Mitsubishi Tanabe Pharma Corporation Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Mitsubishi Tanabe Pharma Corporation Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Mesoblast Ltd Basic Information List
Table Mesoblast Ltd Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mesoblast Ltd Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Mesoblast Ltd Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Mesoblast Ltd Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Ampio Pharmaceuticals Basic Information List
Table Ampio Pharmaceuticals Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ampio Pharmaceuticals Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Ampio Pharmaceuticals Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Ampio Pharmaceuticals Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Diabetic Nephropathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Reata Pharmaceuticals Diabetic Nephropathy Sales Growth Rate (2013-2018)
Figure Reata Pharmaceuticals Diabetic Nephropathy Sales Market Share in United States (2013-2018)
Figure Reata Pharmaceuticals Diabetic Nephropathy Revenue Market Share in United States (2013-2018)
Table GenKyoTex S.A Basic Information List
Table ChemoCentryx Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetic Nephropathy
Figure Manufacturing Process Analysis of Diabetic Nephropathy
Figure Diabetic Nephropathy Industrial Chain Analysis
Table Raw Materials Sources of Diabetic Nephropathy Major Players/Suppliers in 2017
Table Major Buyers of Diabetic Nephropathy
Table Distributors/Traders List
Figure United States Diabetic Nephropathy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Diabetic Nephropathy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Diabetic Nephropathy Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Type in 2025
Table United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Application in 2025
Table United States Diabetic Nephropathy Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Diabetic Nephropathy Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetic Nephropathy Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources